Looking to build its position as a player for microarray-based proteomic, chromatin immunoprecipitation (ChIP)-on-chip, and bacterial expression applications, Dutch reagent shop Kreatech Biotechnology plans to launch several new kits over the next few months, according to a company official.

Specifically, Brent Keller, general manager and vice president of commercial operations at Kreatech, told BioArray News last week that the company will launch three new kits for proteomics applications by the end of this year.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.